Fairbanks Chosen as Finalist in M2D2 $200K Challenge

Fairbanks Pharmaceuticals has been selected from a pool of over 100 applicants as one of 20 finalists in the 7th Annual M2D2 $200K Challenge.

M2D2 describes the challenge this way:

The $200K Challenge is a global competition for early-stage medical device and biotech innovations. The goal of the $200K Challenge is to identify the most promising innovations that will move the needle in healthcare.

On March 28, the finalists will make their pitches to a live audience and a panel of expert judges. Awards totaling up to $200,000 will be presented at a ceremony on April 10. Tickets for the events and a list of the finalists are available here.